The government is in contact with the Serum Institute of India and other pharmaceutical companies to look at ways that they can ramp up production of anti-Covid vaccines at a time when several states have said that they are running out of stocks of Covishield and Covaxin, the two vaccines cleared for use in India.
Asked whether the government would financially assist the Serum Institute of India to ramp up manufacturing capability to the tune of Rs 3000 crore, Dr K VijayRaghavan told NDTV: "All the options are there... There are investors in India and abroad. There are Indian banks. There are government programmes. There are government R&D programmes... All of this will add up to ensuring that manufacturing goes [on]. I don't see that as any resource being limited to expanding manufacturing."